Lidocaine Accord (Lidocaine Hydrochloride)

Lidocaine works by blocking voltage‑gated sodium channels on neuronal membranes, which prevents the rapid influx of sodium ions needed for depolarisation. This inhibition stops the initiation and propagation of nerve impulses, resulting in a temporary loss of sensation and pain perception at the site where the drug is applied.

The appropriate dose of Lidocaine Accord is determined by the prescribing clinician based on the specific procedure, route of administration, patient weight, and overall health status. Healthcare providers calculate the total allowable dose to stay within safety limits and adjust it according to clinical response.

Safety data for Lidocaine Accord in pregnancy and lactation are limited. The drug should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should assess each case individually and consider alternative options when appropriate.

To order Lidocaine Accord, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration of action, making it suitable for many short‑ to medium‑duration procedures. Compared with agents such as bupivacaine, lidocaine has a shorter half‑life and lower risk of prolonged cardiotoxicity, but may require repeat dosing for longer surgeries.

Lidocaine Accord should be stored at temperatures below 25 °C, protected from direct sunlight, moisture and extreme temperature fluctuations. Keep the solution in its original packaging until use, and discard any product that appears discoloured, cloudy, or has particles.

Lidocaine Accord is administered by a qualified healthcare professional via epidural, intramuscular or intravenous injection, depending on the clinical indication. The solution is injected directly into the target tissue or vascular space, and the dose is carefully calculated to achieve effective anesthesia while minimizing systemic exposure.

Serious risks include cardiac arrhythmias, seizures, methemoglobinemia, and severe allergic reactions such as anaphylaxis. These events are rare but require immediate medical attention. Monitoring of cardiovascular and neurological status during and after administration helps detect early signs of toxicity.

Lidocaine Accord should be avoided in patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block, uncontrolled arrhythmias, or significant hepatic impairment that could impair drug metabolism. Clinicians must evaluate each patient’s medical history before use.